Moderna

-$18.40 (-5.42%) As of 4:17 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

CEO
Stéphane Bancel
Employees
1,300
Headquarters
Cambridge, Massachusetts
Founded
2010

MRNA Key Statistics

Market Cap
129.64B
Price-Earnings Ratio
42.39
Dividend Yield
—
Average Volume
10.45M
High Today
$335.75
Low Today
$317.18
Open Price
$333.00
Volume
4.88M
52 Week High
$497.49
52 Week Low
$65.49

MRNA News

BenzingaOct 21

Corona Doom 2.0: Carter Worth Warns That Vaccine-Maker Moderna May Have Further To Fall. What To Do If You're Long.

Moderna: Look Out Below? COVID-19 vaccine maker Moderna, Inc. (NASDAQ: MRNA) was our top name in late August... Screen capture via Portfolio Armor on 8/26/202
BenzingaOct 21

Baillie Gifford Trimmed Positions In Alibaba, Tesla, Nio, Moderna In Q3, Here's What It Bought Instead - Alibaba

Investment firm Baillie Gifford lowered exposure in Tesla Inc (NASDAQ:TSLA), Alibaba Group Holding (NYSE:BABA) and Nio Inc (NYSE:NIO) in the third quarter and s
BenzingaOct 18

Why Moderna Shares Are Rebounding From Friday's Losses - Moderna

Moderna, Inc. (NASDAQ:MRNA) shares have followed a downtrend ever since completing a double top formation in late September. After bottoming in early October, t

MRNA Earnings

-$0.69
$1.69
$4.08
$6.46
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure